Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

12.13
BATS BZX Real-Time Price
As of 10:31am ET
 -0.06 / -0.49%
Today’s Change
10.86
Today|||52-Week Range
46.38
-64.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$350.0M

Company Description

Fluidigm Corp. develops, manufactures and markets microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Contact Information

Fluidigm Corp.
7000 Shoreline Court
South San Francisco California 94080
P:(650) 266-6000
Investor Relations:
(650) 266-6081

Employees

Shareholders

Mutual fund holders72.79%
Other institutional35.57%
Individual stakeholders2.94%

Top Executives

Gajus Vincent WorthingtonPresident, Chief Executive Officer & Director
Fredric T. WalderChief Operating Officer
Vikram JogChief Financial Officer
Robert C. JonesExecutive Vice President-Research & Development
Mai Chan YowExecutive Vice President-Worldwide Manufacturing